Experts are rapidly focused on retatrutide molecules, a novel dual stimulator targeting both GLP-1 and GIP receptors. This particular strategy seems to offer significant potential for weight loss and associated health issues . Early clinical investigations have shown positive results, implying a potential shift in how we handle excess weight and l